ADHD Med Exposure in Utero Not Tied to Long-Term Impact in Offspring

FRIDAY, Feb. 24, 2023 (HealthDay News) -- Neurodevelopment and growth in offspring is not negatively impacted by prenatal exposure to attention-deficit/hyperactivity disorder (ADHD) medication, according to a study published online Feb. 9 in Molecular Psychiatry.
Kathrine Bang Madsen, Ph.D., from Aarhus University in Denmark, and colleagues assessed whether in utero exposure to ADHD medication was associated with adverse long-term neurodevelopmental and growth outcomes in offspring. The analysis included 898 children exposed to ADHD medication in utero and 1,270 children whose mothers discontinued ADHD medication before pregnancy, who were born from 1998 to 2015 and followed through 2018.
After adjusting for demographic and psychiatric characteristics of the mother, the researchers observed no increased risk for any offspring developmental disorders for either combined (adjusted hazard ratio, 0.97; 95 percent confidence interval, 0.81 to 1.17) or separate subcategories. In the negative control and sibling-controlled analyses, there was no increased risk seen for any subcategories of outcomes.
"We can see that the number of women of childbearing age who are medicated for ADHD is rapidly increasing, and therefore it is very important to garner more knowledge to be able to counsel these women," a coauthor said in a statement. "There are still unknowns, but these results may contribute to women making informed decisions about using ADHD medication during pregnancy."
Several authors disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Related Posts
AHA News: She Thought She Had Bronchitis, But the Problem Was Her Heart
MONDAY, June 13, 2022 (American Heart Association News) -- Terita Grier has...
Los casos de viruela del simio se disparan: EE. UU. pide más vacunas y aumenta las pruebas
VIERNES, 15 de julio de 2022 (HealthDay News) -- Los casos de viruela del mono...
Aumenta la tasa de ACV de los estadounidenses jóvenes, mientras la de las personas mayores se reduce
JUEVES, 3 de febrero de 2022 (HealthDay News) -- Aunque ha habido un declive...
Lifetime Ovulatory Years Linked to Epithelial Ovarian Cancer
WEDNESDAY, March 1, 2023 (HealthDay News) -- Lifetime ovulatory years (LOY) are...
